Ortho-Tri-Cyclen Lo Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Contraceptive Hormones and Women With Cystic Fibrosis
Condition: Cystic Fibrosis Exacerbations While on and Off Hormonal ContraceptionInterventions: Other: Non-hormonal period; Drug: Ortho-cyclen, Ethinyl estradiol/norgestimate, 0.035 mg/0.250 mgSponsors: University of Pennsylvania; Society of Family PlanningRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2014 Category: Research Source Type: clinical trials
A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different Facilities
Condition: HealthyInterventions: Drug: Norgestimate /Ethinyl estradiol tablets (NGM/EE) (Wet Process); Drug: Norgestimate /Ethinyl estradiol tablets (NGM/EE) (Dry Process)Sponsor: Janssen Research & Development, LLCCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2014 Category: Research Source Type: clinical trials
Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects
Condition: HealthyInterventions: Drug: lomitapide; Drug: EE/norgestimateSponsor: Aegerion Pharmaceuticals, Inc.Completed - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2014 Category: Research Source Type: clinical trials
